Physician profile
Rajan S Gupta
NPI 1114997962
$28,084.06
in general payments reported to CMS, 2019-2025
10 companies · $27K in 2025
The $27K reported for 2025 was more than what 98% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $341 · 2022: $161 · 2023: $61.46 · 2024: $149 · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $27K · Food and Beverage: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $27,256.96 |
| Food and Beverage | $325.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bracco Diagnostics INC. | $27,256.96 | 2025 | |
| Si-Bone, INC. | $523.61 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $132.22 | 2022 | |
| International Rehabilitative Sciences, INC | $36.25 | 2023 | Rs 4i Plus Sequential Stimulator |
| Acumed LLC | $29.49 | 2024 | Acumed |
| Alexion Pharmaceuticals, INC. | $28.88 | 2022 | |
| Fidia Pharma USA INC. | $23.98 | 2024 | Hyalgan |
| Pfizer INC. | $19.10 | 2024 | |
| Medtronic, INC. | $17.97 | 2024 | Intellis Adaptivestim |
| Curonix LLC | $15.60 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajan Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.